Ben Barres, a pioneering neuroscientist whose work made fundamental contributions to our understanding of glial biology and whose efforts to advance the cause of increasing diversity in science were remarkably impactful, passed away on December 27, 2017. Ben was our colleague, our advisor, our mentor, and our friend. For the better part of our professional lives, we spent part of almost every day debating with Ben through conversations, emails, or texts. What follows is our combined personal reflections on a few of the lessons we learned from him over the years.
What makes a life as impactful as Ben's? Ben was a pioneering scientist, and his love of glia brought him and his lab a legion of scientific contributions that have changed, and will continue to change, how we think about brain development, aging, regeneration, and neurodegenerative diseases. Ben was also a passionate mentor who always placed the well-being and success of his trainees ahead of his own, inspiring and helping many of the people who came through his lab to establish successful independent careers. However, Ben's life also left a broader mark on science and society, through his engagement with a host of issues faced by young scientists (Barres, 2006 (Barres, , 2013 (Barres, , 2017 . As he told us, it was worth thinking about one's career as more than just a matter of running a successful lab-he viewed his job as a platform that could be used to have an impact on the things that mattered to him-his trainees, Stanford, the scientific community, and, even more broadly, diverse communities of young people trying to choose their own paths around the world. Thinking in this very broad, high-level way is unusual for scientists, but to devote as much time and energy to these causes as Ben did is nearly unique. And yet, it is these things that touched so many lives and made his life so impactful.
In thinking about how Ben achieved so much, one cannot escape thinking about Ben's passion for everything he cared about. With Ben, there were never any half-measures-whatever the cause or the situation, Ben was completely devoted to achieving the right outcome. It might have been his current diet or the latest research going on in his lab. It could have been a local injustice affecting students or postdocs or a broader matter of fairness in the scientific community. While most of us accumulate responsibilities, Ben kept life simple; he lived like a graduate student, albeit one who could afford an espresso machine and a racing bicycle, his only two extracurricular indulgences. At the same time, he kept the same purity of purpose that every scientist feels when they first start working in a lab-some combination of curiosity, challenge, and will. In many ways, Ben remained a trainee throughout his adult life; all he needed to be happy was an important question to answer, the possibility of some data, and the time to read whatever he wanted. To this, Ben added an endless fascination with what people were doing and, most importantly, how he might help them. If it appeared that someone might share a passion for science, he would go out of his way to learn about them-any graduate student wandering the halls at night could be drawn in for an inspiring hour-long talk.
Ben's first and life-long passion was his science. There is a quote from Asimov on his office door that he truly held dear: ''There is a single light of science, and to brighten it anywhere is to brighten it everywhere'' (Isaac Asimov, The Road to Infinity). Ben's love of science was born out of the simple joy of discovering and understanding, and he was always filled with an unyielding curiosity toward his scientific questions. From the start of his graduate career, Ben was fascinated by ''the magic and mystery of glia,'' as he put it, and his insistence to ask a ''big'' question always led him back to the same point: what do glia do? While a first-year doctoral student in Harvard Medical School, Ben rotated in Linda Chun's lab, where he first started to study these enigmatic non-neuronal cells. He carried his interest in glia over to his PhD advisor David Corey's lab, where he performed an impressive number of physiological studies in which, contrary to the thinking of the time, he discovered that astrocytes and oligodendrocytes had substantial active conductances. After finishing his PhD, Ben continued his training with postdoctoral studies in Martin Raff's lab at University College London. Here, Ben developed a series of techniques that enabled him to purify and culture pure populations of neurons, astrocytes, and oligodendrocyte lineage cells to address important questions about neuron-glia interactions. In 1992, armed with these physiological and cell biological approaches and a relentless drive to answer his questions, Ben started his own lab in the Department of Neurobiology at Stanford University, where he remained throughout his career. From there, Ben's lab made critical contributions to diverse topics such as how astrocytes drive the formation of new synapses, how synapses are pruned and sculpted during development by glia, and how oligodendrocytes can myelinate Ben Barres an axon. His lab also continued to pioneer new techniques to purify different kinds of glia and then used these approaches to understand how glia reacted under disease conditions and during aging. Finally, his lab also created searchable, cell-specific gene expression databases for glia, which proved invaluable to a broad community of investigators. These databases were also one of Ben's greatest joysand the basis for his constant cries of ''this gene is at cosmically high levels'' and ''have you looked in our datasets?'' Ensuring fairness in science was Ben's lifelong goal. If a process or competition was fair, Ben was fine with any outcome. And even though Ben was always strongly opinionated and did not refrain from making his thoughts heard, he knew when to listen. Above all, Ben was respectful of others' ideas. But, if a process was unfair, and a person or an organization was unjust, Ben would be relentless in demanding change and would never take no for an answer. Lacking any concern for appearances, Ben would freely express his views in terms that the polite, restrained world of academia was often unaccustomed to hearing. His carefully articulated articles confronting biases against women in science, choosing a faculty mentor, or, most recently, the treatment of postdocs were all moderated versions of much more passionately held opinions (Barres, 2006 (Barres, , 2013 (Barres, , 2017 . Because of this unwavering dedication to achieving the most ethical outcome, many people sought his help and wisdom when they felt something was wrong, making him an important moral compass. And to be fair, while he could be calm and objective, he could also engage what we jokingly called the ''nuclear option'' when diplomacy failed, calling out failures to act in the strongest possible terms. Speaking truth to power was Ben's specialty, and his efforts made him a few enemies, but legions of friends. This was born out of his utmost respect for people but was never tempered by fear of speaking out against injustice, flawed assumptions, or (it should be said) a neuroscience program that did not consider glia to be important! To speak your mind when there are no consequences is one thing, but to speak out when you know that there will be professional consequences is another. Ben did both and didn't worry about the price.
One of Ben's causes, upon which he undoubtedly had significant impact, was the dearth of women and minorities in science. Ben was transgendered, transitioning from female to male in his forties, and his initial engagement with gender in science issues came from his personal experience with how unfairly he had been treated when he was a woman. In his commentary ''Does gender matter?'' (Barres, 2006) , Ben provided a strong, data-driven response to rebut the proposition that women were not advancing in science because of their innate inabilities, but rather were being held back by systemic barriers to their progress. From that point onward, Ben used his scientific platform not only to communicate his science, but also to push back against these barriers. Ben was incredibly persuasive and absolutely fearless in talking to whoever was in charge of any policy he identified as unfair. He wrote letters to the leaders of the NIH, HHMI, The Gordon Conferences, Keystone, Cold Spring Harbor, and many others, protesting a host of rules and practices that make it hard for women and minorities to advance in science. Remarkably, he was successful on many fronts, both big and small. The selection processes for the NIH Pioneer Awards and HHMI investigators changed after Ben's engagement, policies that guard against harassment at major meetings are in place because of Ben, and Blackburn House at Cold Spring Harbor has more portraits of female scientists because Ben rightly felt that a place that serves as the intellectual heartland for so many scientists needed to provide some more diverse role models. He refused to accept speaker invitations at meetings that didn't have a diverse representation of the field, offering his spot to women and minority scientists when he could and castigating organizers who refused to change their program. He also highlighted the successes of female and minority scientists whenever he could so that others in early stages of their careers could hear positive stories and be inspired Ben always posted favorite quotes, glia drawings, pictures, and ''Thank you'' cards from young, aspiring scientists on his office door. It has also been a long-standing tradition that Barres lab members would leave messages to Ben when he left for a trip. Barres lab members continued this tradition and decorated his door with a festive sign ''Welcome to the Department of Gliobiology. '' to stay in science. These influences will have a long-lasting impact on many fields, a hard thing to measure, but Ben's efforts to increase equality, fairness, and engagement in science are sure to pay dividends for years. From small beginnings can be born profound responses, a lesson learned from Ben that we should all heed.
For someone who had achieved so much, Ben remained truly humble and engaging throughout his career. He was happy to use his inability to remember faces as a disarmingly easy way to start a conversation with everyone and anyone who smiled at him. Even people who interacted with Ben almost daily for years occasionally experienced the quizzical look on his face when he saw us somewhere out of context and heard the familiar question ''who are you?'' Only later did we learn that this was his default greeting, a way to make the senior faculty member unassuming, thereby turning a weakness into a strength. More importantly, he was happy to engage with anyone's problem, big or small, recognizing that even a small effort of his might one day have a big impact on someone else. After Ben's diagnosis with pancreatic cancer nearly two years ago, it has become clear that Ben's personal outreach has helped so many people scattered around the world, with each one having a personal story about how Ben went out of his way to help them. From the boy who lived next door, to a young medical student, to someone from the LGBTQ community, or a junior faculty member working in an unrelated field, Ben always found time to help those who needed it. We could say that we don't know how he managed, but of course we know exactly how Ben had the time to help so many people-he was nearly always the last to leave the lab, usually around midnight, every day of the week and would apparently write emails in the few hours per day that he might have spent sleeping. His energy was simply tremendous; when it came to science, every person's injustice was Ben's.
Ben tackled his illness with the same courage that propelled his engagement with issues of fairness. In the three months before he was diagnosed with pancreatic cancer, Ben suffered a series of venous clots in his legs, which we joked about as the occupational hazard of scientists who spend too much time on airplanes. In March 2016, he had a heart attack and drove himself to the hospital. After a few days, Ben learned the hard news of his diagnosis and emailed the department and his past and present trainees that night, conveying a strikingly upbeat tone. Visiting Ben in the hospital the next day was the first time any of us had seen Ben in a depressed state-the normal reaction of anyone under the circumstances. That mood lasted one day. The next day, he woke up, having made a list during the night of the things he needed to do, and said he had better get busy. He was upset that chemotherapy was going to prevent him from working four days every two weeks, until one of his graduate students pointed out to him that four days off every two weeks was what most people called ''weekends.'' Having been diagnosed at a very late stage in his disease, he responded with an off-scale response to the chemotherapy and immunotherapy-one more time that Ben was a five-sigma exception to the rule-as he went back to working and biking for nearly a year and a half. During the darkest of days of his illness, Ben's upbeat response that he was doing ''a second postdoc'' was never truer. He poured over volumes of data, excitedly discussed new avenues for research, and to the chagrin of many in the department, cut back on his administrative duties. For those who were fortunate to spend time with Ben during these days, there was nothing more heartening than seeing his face light up with the prospect of discussing a new paper outline, grant proposal, or idea to be followed up on in the lab. Over that time, he also joked countless times about his death, as we debated whether someone dying of cancer should be able to escape updating his animal protocol. Or beginning his comment on some departmental decision by saying ''this won't affect me because I'll probably be dead before it happens, but.'' It was a calculated effort on Ben's part to make his death easier for us, an effort that was only partially successful.
When his health turned for the worse at the start of November 2017, it was clear that Ben didn't have much time. Rather than worry about himself, Ben's chief worry, and indeed motivation for living, was whether he had updated the letters for all of his trainees. For Ben, his trainees were his family, and their success was what he truly lived for. He spent his final days writing and revising letters for his many trainees, meticulously updating them, making sure that every single one had what they needed to move ahead in their careers. With each letter, Ben remembered the wonderful science his lab produced, rejoiced in the talents of everyone who worked with him, and felt assured his trainees will continue to ask the big questions about glia and brain. Ben often assured us that at the end of his life he had no regrets, but he also added, jokingly, ''It is killing me that I am dying now, when there are still so many unknowns.'' Shane A. Liddelow, 1 Cagla Eroglu, 2 and Thomas R. Clandinin 3, *
